Europe Diabetic Foot Ulcer Treatment Market Report: Market Size & Forecast 2026

Diabetic foot ulcers represent a significant and growing healthcare challenge in Europe, affecting a substantial portion of the continent's diabetic population. The market includes various product categories designed to promote wound healing, prevent infection, and reduce the risk of lower-extremity amputations. Treatment approaches range from traditional dressings to advanced biologic therapies, with the choice depending on ulcer severity, type, and patient condition.

• •Market valued at approximately $1.68 billion in 2025
• •Primary treatment segments include wound care dressings and biologics
• •Major end users are hospitals and homecare settings

The market's expansion is primarily fueled by the increasing prevalence of diabetes across European countries, compounded by aging population trends. Growing awareness of the importance of early wound management and the rising costs associated with untreated ulcers are pushing healthcare providers toward more proactive treatment strategies. Additionally, reimbursement policies in many European nations that cover advanced wound care products are supporting market adoption.

• •Rising diabetes incidence and aging demographics across Europe
• •Growing emphasis on early intervention to prevent amputations
• •Reimbursement support for advanced wound care therapies in multiple countries

The market is segmented by ulcer type into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers, each requiring different treatment approaches. Treatment categories include advanced wound care dressings, biologics, and other therapeutic options, with applications spanning hospitals, clinics, and homecare settings. Geographic variation exists across European nations, with Western Europe generally accounting for larger market shares due to higher healthcare spending and better access to advanced treatments.

• •Ulcer types include neuropathic, ischemic, and neuro-ischemic categories
• •Treatment segments: biologics, wound care dressings, and other therapies
• •Geographic distribution varies, with Western Europe representing the largest regional market

What are the recent trends and outlook?

The market is witnessing a shift toward more sophisticated biologic treatments and regenerative medicine approaches that promote natural healing processes. There is increasing emphasis on developing solutions for home-based care, driven by patient preference and cost-containment efforts within healthcare systems. Looking forward, the market is expected to maintain steady growth through 2030, supported by ongoing product innovation, expanded indications for existing treatments, and continued improvements in diabetes management across the region.

• •Growing adoption of advanced biologics and regenerative therapies
• •Expansion of home-based wound care treatment options
• •Projected to continue growing through 2030 amid ongoing innovation